Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neurosurgical patients with a history of depression.
Epistemonikos ID: 06ac4d5497a62577f693ea051ee094653e94ed2a
First added on: May 10, 2024